Nov 27,2019 : Zebra Medical Vision received US FDA clearance for its artificial intelligence-powered solution in order to identify pleural effusion, also known as “water on the lungs.”Zebra Medical Vision received three previous FDA clearances for AI-powered medical imaging technologies, has now received approval for its HealthCXR device for the identification and triage of pleural effusion in chest x-rays.
Experience and deep-learning will automatically help to identify findings indicative of pleural effusion based on CR, DR and DX scans and than speedily notifying radiologists and enabling them to both effectively address and prioritize urgent cases.
In the United States, approx 1.5 million people diagnosed annually with pleural effusion, most commonly caused by congestive heart failure, pleural infection and malignancy, approximately one-third of pleural effusion patients die within one year. https://fda.einnews.com/article__detail/503386785-zebra-wins-fda-clearance-for-ai-based-pleural-effusion-diagnosis-tech?vcode=XIbw
